But on Friday, the U. Food and Drug Administration approved a new medication that will boost libido in women with low sexual desire, so that they too can have an enjoyable sex life. Hylton V.
June 24, am Updated June 24, pm. Federal regulators approved a medication Friday to boost low sex drive for women that comes in the form of a shot to the thigh or abdomen. Viagra for men has been around since the s.
The medication, approved Friday by the Food and Drug Administration, is only the second approved to increase sexual desire in women, a market that drugmakers have been trying to cultivate since the blockbuster success of Viagra for men in the late s. The other drug is a daily pill. The company declined to release price information.
By definition, you may be diagnosed with hypoactive sexual desire disorder if you frequently lack sexual thoughts or desire, and the absence of these feelings causes personal distress. Whether you fit this medical diagnosis or not, your doctor can look for reasons that your sex drive isn't as high as you'd like and find ways to help. Most women benefit from a treatment approach aimed at the many causes behind this condition.
But how exactly does the drug work, and what makes it different from the other medication on the market? The drug, called bremelanotide brand name Vyleesi has been approved to treat premenopausal women with hypoactive sexual desire disorder HSDDa condition in which low sexual desire causes personal distress, the FDA said in a statement. Women self-administer the injection under the skin of the abdomen or thigh at least 45 minutes before anticipated sexual activity.
The Food and Drug Administration on Friday approved a new medication for premenopausal women whose flagging libidos are a source of personal distress or relationship difficulties. The condition, which was first recognized in its gender-specific form inis thought to affect as many as 1 in 10 women before the onset of menopause, and many more after that. Hylton V.
The other drug is a daily pill. The company declined to release price information. The most common side effect in company studies was nausea.
An as-needed injectable treatment offers women another option for treating low libido, but it may not work for every woman. Women finally have another FDA-approved drug that promises to boost their sex drive, bringing the total number of medications to exactly… two. Women inject the new drug themselves in the thigh or abdomen using an auto-injector.
On Friday, the FDA approved a new drug meant to boost female libido, only the second of its kind to enter the market. Vyleesi, whose generic name is bremelanotide, follows the launch of the drug Addyi, a daily pill meant to treat hypoactive low sexual desire disorder HSDD in premenopausal women. While Vyleesi is also approved to treat HSDD, it differs from Addyi because it comes in the form of an injectable rather than a pill and is only to be used before sex rather than on a daily basis.
When it comes to medications for treating female sexual dysfunction, options are limited. Taken in the form of a pink tablet, Addyi is a non-hormonal option indicated for premenopausal women. Addyi is intended for women experiencing hypoactive low sexual desire disorder regardless of the sexual partner, activity, or situation. HSDD is just one type of female sexual dysfunction, a disorder that refers to a reduction or absence of sexual interest in a woman that lasts six or more months and causes distress or interpersonal difficulties.